Resources from the same session
613MO - A phase I clinical trial evaluating exarafenib, a selective pan-RAF inhibitor in combination with binimetinib in NRAS-mutant (NRASMut) melanoma (Mel) & BRAF-altered solid tumors
Presenter: Philippe Cassier
Session: Mini oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
614MO - Type II RAF inhibitor tovorafenib in recurrent/refractory (R/R) melanoma or other solid tumors with RAF fusions and/or RAF1 amplification
Presenter: Maria Vieito
Session: Mini oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
615MO - Phase I/II study of D3S-001, a second generation KRAS G12C inhibitor in advanced/metastatic solid tumors with KRAS G12C mutations
Presenter: Byoung Chul Cho
Session: Mini oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
616MO - Long-term follow-up of single-agent divarasib in patients with KRAS G12C-positive solid tumors
Presenter: Elena Garralda
Session: Mini oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
Invited Discussant 615MO and 616MO
Presenter: Christophe Massard
Session: Mini oral session: Developmental therapeutics
Resources:
Slides
Webcast
617MO - Safety and tolerability of INCB123667, a selective CDK2 inhibitor, in patients (pts) with advanced solid tumors: A phase I study
Presenter: Matteo Simonelli
Session: Mini oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
618MO - Phase Ib/II first-in-class novel combination trial of next generation CDK4-selective inhibitor PF-07220060 and next generation CDK2-selective inhibitor PF-07104091 in HR+ HER2- metastatic breast cancer and advanced solid tumors
Presenter: Timothy Anthony Yap
Session: Mini oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
619MO - Camonsertib (cam) monotherapy in patients (pts) with advanced cancers harboring ATM loss-of-function (LoF)
Presenter: Benedito Carneiro
Session: Mini oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
Invited Discussant 617MO, 618MO and 619MO
Presenter: Alex A. Adjei
Session: Mini oral session: Developmental therapeutics
Resources:
Webcast